Lymphoma News & Leukemia News & Myeloma News from Medical News Today

Lymphoma / Leukemia / Myeloma News

Lymphoma / Leukemia / Myeloma News

The latest Lymphoma News & Leukemia News & Myeloma News articles published daily. Includes news on hematological malignancies (blood and lymphatic cancers), Hodgkin's Disease, Epstein-Barr Virus and more.

Add this Lymphoma rss news feed to your rss reader:

Latest News

Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation

07 November 2009

For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a...
[read article]

ERYtech Pharma Starts Its Pivotal Clinical Trial For GRASPA(R) In Acute Lymphoblastic Leukaemia

06 November 2009

ERYtech Pharma announces the start of its pivotal clinical trial for GRASPA®, its lead product in Acute Lymphoblastic Leukaemia. This phase III trial has begun in France and will be enlarged to a European scale...
[read article]

FDA Approves Gloucester Pharmaceuticals' ISTODAX(R) For Patients With Cutaneous T-cell Lymphoma

06 November 2009

Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy...
[read article]

Lymphoma / Leukemia / Myeloma News Articles Archive - Page 1

06 November 2009

Pivotal Data Published In The Journal Cancer Demonstrate That TREANDA Induced Durable Responses In Relapsed Indolent Non-Hodgkin's Lymphoma

Sunesis' Voreloxin Receives FDA Orphan Drug Designation For Acute Myeloid Leukemia

Stem Cell Therapy International, Inc. And Histostem Korea Announce Providing Hematopoietic Stem Cell To Queen Mary Hospital, Hong Kong

New Data On Bendamustine Offers Hope To Non-Hodgkin's Lymphoma Patients Resistant To Standard Therapy

04 November 2009

Two Genes Co Operate To Cause Aggressive Leukaemia

03 November 2009

Immune Therapy Can Protect Against Or Treat Later Lymphoma

02 November 2009

Drug Shows Promise In Treating Dangerous Complication Of Erectile Disorder

31 October 2009

Immunotherapy Demonstrates Long-Term Success In Treating Lymphoma

Sunesis Completes Enrollment Of Voreloxin REVEAL-1 Trial In Acute Myeloid Leukemia

30 October 2009

Lymphoma Research Foundation Announces Recipients Of CLL/SLL Research Initiative Grants

29 October 2009

Innovative National Clinical Trial Network Launched By Rare Cancer Charity

28 October 2009

Lymphoma Patients Benefit From Exercise

27 October 2009

FDA Approves New Treatment For Chronic Lymphocytic Leukemia

26 October 2009

Professor Suzanne Cory Awarded 2009 Pearl Meister Greengard Prize

25 October 2009

Lower-Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

23 October 2009

Pixantrone Produces High Rates Of Complete Remission In Multiple Relapsed And Refractory Indolent And Aggressive Non-Hodgkin's Lymphoma

22 October 2009

Millennium Initiates Phase II Trial For Diffuse Large B-Cell Lymphoma

21 October 2009

Novartis Drug Tasigna(R) Meets Primary Endpoint In Pivotal Trial Against Gleevec(R) As First-line Treatment In Chronic Myeloid Leukemia Patients

19 October 2009

New Chromosomal Abnormality Identified In Leukemia Associated With Down Syndrome

14 October 2009

Discovery Reveals Gene Activity Networks That Let Tumors Thrive And Suggests New Modes Of Therapy

13 October 2009

Antisoma's AS1411 Gains US And EU Orphan Drug Status For Acute Myeloid Leukaemia

Genome-Wide Meta-Analysis Identifies 22 Regions Associated With Blood Cell Traits

Celator(R) Pharmaceuticals Completes Enrollment Early In Phase 2 Study Of CPX-351 In Newly Diagnosed AML

08 October 2009

Antisoma To Amend ACCEDE Phase III Study Of AS1413

High-sensitivity Bone Marrow Aspiration Technology Enhances Leukemia Cell Detection

Leukemia Cell Detection Enhanced By High-Sensitivity Bone Marrow Aspiration Technology

Genzyme Receives FDA Complete Response Letter For Clolar

Regulation Of Hematopoietic Stem Cell Development Shown By MDC Scientists

07 October 2009

Survival For High Risk Childhood Leukemia More Than Doubled By New Treatment

'Treason' By Immune System Cells Aids Growth Of Multiple Myeloma

Seattle Genetics Announces Discontinuation Of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical Trial

Allos Therapeutics Announces U.S. Availability Of FOLOTYN™ (pralatrexate Injection) For Relapsed Or Refractory Peripheral T-Cell Lymphoma

06 October 2009

New Target For Treating Leukemia Identified By Inventive Combination Of Research Approaches

01 October 2009

Researching The Cause Of Programmed Cell Death

New Knowledge About Bone Marrow Transplants Can Help Leukemia Patients

Mabthera(R) (Rituximab) Approved In UK For Relapsed And Difficult-To-Treat Patients With Most Common Leukaemia

29 September 2009

News From The American Journal Of Pathology, October 2009

New Route To Leukaemia Uncovered

28 September 2009

Allos Therapeutics' FOLOTYN™ First And Only FDA-Approved Therapy For Relapsed Or Refractory Peripheral T-cell Lymphoma

27 September 2009

FDA Approves First Drug For Treatment Of Peripheral T-cell Lymphoma

26 September 2009

Funding Boost To Speed Up Cancer Detection For Canadian Research Network Led By University Of Toronto Chemist

25 September 2009

Genzyme's Campath Meets Primary Endpoint In Phase 3 Combination Therapy Trial For Chronic Lymphocytic Leukemia

2 Highly Prized NIH Director's Awards Won By Duke Biomedical Scientists

23 September 2009

ESMO Recognizes Leading Oncologists With Prestigious Awards

Highlights From The John Theurer Cancer Center And Leukemia And Lymphoma Society

Obesity Hinders Chemotherapy Treatment In Children With Leukemia

Experimental Drug Lets B Cells Live And Lymphoma Cells Die

22 September 2009

Internationally Renowned Physician-Scientist Joins USC Norris Cancer Center And Keck School Of Medicine

Combining Two Anticancer Drugs Improves Remission Rates In Patients With Primary Central Nervous System Lymphoma

FDA Grants Priority Review Status To Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection

19 September 2009

Anemic Patients With MDS Gain Long-Term Benefits From Erythropoietin And Myeloid Growth Factor Hormones

17 September 2009

Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line For Maintenance

Increase In Cancer Risk After Northern Italian Industrial Accident

Dexamethasone-Based Therapy Shows Improvement In Survival For Children With Acute Lymphoblastic Leukaemia

15 September 2009

Loyola Receives $2 Matching Grant From Coleman Foundation

The Leukemia & Lymphoma Society To Fund Research Focused On Long-Term And Late Effects Of Cancer Treatment

12 September 2009

Radioimmunotherapy Drug Cleared As First-Line Treatment For Non-Hodgkin's Lymphoma

Go To News Page:
[1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles

Terms and Conditions

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


News Archive [link] Web Wikipedia Medical Dictionary [link]